What the Skin Barrier Actually Does Mechanically

The skin barrier — formally called the stratum corneum — is the outermost layer of the epidermis. It is roughly 10 to 20 cells thick and functions as the body's primary interface with the external environment, regulating what passes inward and what escapes outward. Despite its thinness, it performs a continuous and mechanically precise job that most topical skincare products are designed to support, supplement, or temporarily mimic.

This piece covers the mechanical and chemical structure of that barrier: what it is built from, how it controls transepidermal water loss (TEWL), where natural moisturizing factors and lipids fit into that system, and where the structure breaks down in ways that produce unexpected results.

How the Stratum Corneum Holds Water and Blocks Threats

The stratum corneum is often described using a "brick and mortar" model. The bricks are corneocytes — flattened, protein-filled cells that have completed a programmed transformation from living keratinocytes. They are largely composed of keratin filaments and have lost their nuclei. The mortar is an intercellular lipid matrix that fills the spaces between corneocytes and is primarily composed of ceramides, cholesterol, and free fatty acids in roughly equimolar ratios.

Water regulation is the barrier's central mechanical task. The skin continuously loses water vapor through the epidermis by diffusion — this is transepidermal water loss. The lipid matrix acts as the primary resistor to that diffusion. Ceramides, which are long-chain sphingolipids, form lamellar bodies that stack into bilayer sheets inside the intercellular space. These bilayers are hydrophobic and create a tortuous path that slows the movement of water molecules outward. Cholesterol modulates the fluidity and packing density of those bilayers, and free fatty acids contribute to the acidic pH of the skin surface, which sits between approximately 4.5 and 5.5.

That acidic pH is not incidental. It is mechanically important because the enzymes responsible for desquamation — the shedding of corneocytes from the skin surface — are pH-sensitive serine proteases. At the correct pH, these enzymes operate at a controlled rate, releasing corneocytes in an orderly fashion. When surface pH rises, the proteases become overactive, and the barrier can thin or become disrupted faster than it regenerates. This is one mechanism by which alkaline cleansers or repeated water exposure can compromise barrier function.

Alongside the lipid matrix, the barrier contains natural moisturizing factor (NMF) — a collection of water-soluble hygroscopic compounds found inside the corneocytes themselves. NMF is largely derived from the breakdown of filaggrin, a structural protein. The products of filaggrin proteolysis include free amino acids, pyrrolidone carboxylic acid (PCA), and urocanic acid, all of which are capable of binding water molecules and retaining them within the cell. This is the mechanism by which the barrier draws moisture from the environment and keeps corneocytes pliable rather than brittle. The phrase "skin draws" moisture refers precisely to this hygroscopic action of NMF components acting as endogenous skin cell turnover-dependent humectants — their concentration depends on how well filaggrin is being produced and processed in the layers below.

The barrier also acts as a physical and chemical filter. Tight junctions in the stratum granulosum, just below the stratum corneum, provide a secondary seal that limits paracellular movement of larger molecules and pathogens. The combined effect of the lipid matrix, the acidic pH, and the tight junction layer creates a system with multiple redundant mechanisms for excluding irritants, allergens, and microorganisms.

The Components That Build and Sustain the Barrier

Ceramides are the dominant structural lipid in the intercellular matrix, accounting for approximately 50% of the total lipid content. They are synthesized in the keratinocytes, packaged into lamellar bodies, and secreted into the intercellular space during the terminal differentiation of the epidermis. Without adequate ceramide content, the bilayer architecture of the lipid matrix becomes incomplete, and water diffuses outward more freely.

Cholesterol occupies roughly 25% of the lipid matrix. It inserts itself between ceramide chains and prevents the bilayers from crystallizing into an overly rigid structure at lower temperatures. This fluidity regulation is critical — a matrix that is too rigid cannot flex with mechanical movement, and one that is too fluid does not resist water loss effectively.

Free fatty acids, primarily long-chain saturated and unsaturated varieties, make up the remaining ~25% of barrier lipids. They contribute to the overall charge and packing of the bilayer, and their presence helps maintain the acidic surface pH that governs enzyme activity.

Filaggrin is a structural protein produced in the granular layer of the epidermis. Its proteolytic breakdown generates the NMF components that give corneocytes their water-binding capacity. Genetic variants that reduce filaggrin expression are associated with measurably lower NMF concentrations and higher baseline TEWL. Filaggrin is not applied topically — it is synthesized endogenously, which is why topical humectants serve as external supplements to a function that the barrier normally performs from within.

Humectants in topical products — including glycerin, hyaluronic acid, urea, and panthenol — are applied to the skin surface to supplement NMF. These molecules are hygroscopic, meaning they attract and hold water molecules through hydrogen bonding. Glycerin, for example, has multiple hydroxyl groups that form hydrogen bonds with water. Hyaluronic acid, a glycosaminoglycan, can bind water at a high ratio relative to its molecular weight. Urea, which is itself a native NMF component, additionally has keratolytic properties at higher concentrations — it disrupts hydrogen bonds within the keratin network of corneocytes, increasing the permeability of the stratum corneum. This dual action makes urea's behavior concentration-dependent in a way that simpler humectants are not.

Emollients — such as fatty alcohols, plant oils, and esters — fill gaps between corneocytes rather than sitting on top of the skin. They improve the smoothness and flexibility of the stratum corneum surface by integrating into the spaces where lipids are depleted. They do not form a continuous occlusive film the way petrolatum or dimethicone does, but they do reduce the surface roughness that accompanies lipid deficiency.

Occlusives form a physical film on the skin surface that mechanically slows transepidermal water loss by reducing the water vapor pressure gradient at the skin-air interface. Petrolatum, the most studied occlusive, does not penetrate the stratum corneum; it sits within the uppermost layers and reduces TEWL by up to 99% under occlusion conditions. It does not replace ceramides or repair the lipid matrix — it simply slows the rate of water escape while the barrier regenerates from below. Just as a chemical exfoliant dissolves the bonds between corneocytes from the outside in, occlusives work entirely at the surface without altering the underlying architecture.

Where Barrier Mechanics Break Down or Produce Unexpected Results

The most commonly misunderstood failure mode involves humectants in low-humidity environments. Because humectants draw water by hygroscopic action, they draw it from the nearest available source. In ambient humidity below approximately 40%, the nearest source can shift from the external air to the deeper layers of the epidermis — the dermis and the living epidermal layers beneath the stratum corneum. In this scenario, a topical humectant applied without an accompanying occlusive can increase TEWL rather than reduce it, pulling water upward and outward rather than drawing it inward from the atmosphere. The mechanism is the same; the direction of net water movement depends on the humidity gradient.

A second friction point involves over-cleansing. Surfactants that remove sebum and environmental debris also extract intercellular lipids if they are sufficiently amphiphilic and if contact time is long. Repeated exposure to alkaline surfactants raises surface pH, as noted above, accelerating enzymatic desquamation and thinning the stratum corneum faster than it can regenerate. The barrier does not signal this damage immediately — there is often a lag between lipid extraction and the appearance of visible dryness or sensitivity.

Retinol and its derivatives present a related friction point. Retinol accelerates keratinocyte turnover, which increases the rate at which new corneocytes reach the stratum corneum. During the initial phase of use, this accelerated turnover can temporarily outpace the barrier's ability to fully differentiate and lipid-coat new corneocytes, producing a transient period of increased permeability and sensitivity. This is not a failure of the ingredient — it reflects the lag between cellular production and barrier maturation.

Occlusion without barrier repair presents a third misunderstood situation. Applying an occlusive over a disrupted lipid matrix reduces water loss mechanically but does not restore the missing ceramides or correct the pH environment. The barrier may remain functionally compromised even as TEWL measurements improve, because the underlying architecture is still incomplete. Occlusion and barrier repair operate through different mechanisms and do not substitute for each other.

Finally, the molecular-weight dependency of humectant penetration is frequently oversimplified. High-molecular-weight hyaluronic acid (above approximately 500 kDa) does not penetrate the stratum corneum under normal conditions — it remains on the surface and acts as a film-forming humectant there. Low-molecular-weight fragments (below approximately 50 kDa) have been shown in some studies to penetrate into the viable epidermis. Whether surface-level or deeper action is occurring depends on the molecular weight distribution of the specific formulation, not on the ingredient name alone.

What a Moisturizer Label Shows About Barrier Support — and What It Does Not

In the United States, moisturizers are regulated by the FDA as cosmetics rather than drugs, provided they make no drug claims. This means the label is required to list all ingredients in descending order of predominance (the INCI list), but it is not required to disclose the concentration of any individual ingredient. A ceramide-containing moisturizer may list ceramide NP, ceramide AP, or ceramide EOP, but the label will not state what percentage of the formula each represents or whether that concentration is sufficient to meaningfully supplement the intercellular lipid matrix.

The same applies to humectants. Glycerin appearing second on an ingredient list indicates a relatively high concentration. Glycerin appearing twelfth indicates a much lower one. Hyaluronic acid, which is effective at low concentrations due to its high molecular weight and hygroscopic capacity, may appear near the end of a list and still be functionally present at a useful level — but the label alone does not clarify this.

Claims such as "restores the skin barrier" or "strengthens the barrier" are cosmetic marketing claims, not FDA-evaluated drug claims. They are not subject to the same pre-market evidence requirements as OTC drug claims. The label does not indicate whether independent testing has confirmed a measurable reduction in TEWL, an improvement in barrier integrity by electrical impedance, or any other objective measure. The presence of ceramides, fatty acids, and cholesterol in a formulation is consistent with barrier-supportive chemistry, but the label's claim and the mechanism are not the same thing.

Fragrance, listed as a single ingredient entry, may represent dozens of individual chemical compounds that are not individually disclosed. Some fragrance components are known contact sensitizers that can disrupt barrier function through immune-mediated pathways. A label that lists "fragrance" does not indicate whether those components are present at sensitizing concentrations. This is a structural gap in current labeling requirements rather than a product-specific issue.

The skin barrier is not a passive layer — it is a dynamically maintained structure whose function depends on the continuous synthesis of lipids, proteins, and hygroscopic compounds by the living cells beneath it. Topical ingredients can supplement, slow the loss of, or temporarily mimic parts of that system, but the underlying architecture is built and rebuilt by the epidermis itself, on a cycle that no single application can replace.

Note: This explains how skincare ingredients and products work. It is not a skincare routine, it does not diagnose or treat a skin condition, and it is not a substitute for a dermatologist. Check the cited sources for current guidance.